The identification of surface proteins of Burkholderia pseudomallei

Sarah V Harding1, Mitali Sarkar-Tyson, Sophie J Smither

  • 1Dstl, Porton Down, Salisbury, Wiltshire SP4 0JQ, UK. svharding@dstl.gov.uk

Vaccine
|February 10, 2007
PubMed

Insights

Researchers identified nine key surface proteins of Burkholderia pseudomallei, the cause of melioidosis. These proteins are potential targets for developing new vaccines and diagnostics against this dangerous human pathogen.

Area of Science:

  • Microbiology
  • Immunology
  • Proteomics

Background:

  • Melioidosis is a serious human disease caused by Burkholderia pseudomallei, endemic in Southeast Asia and Northern Australia.
  • Currently, no effective treatments or vaccines exist for melioidosis.
  • Surface proteins are critical for host-pathogen interactions and are promising targets for vaccine and diagnostic development.

Purpose of the Study:

  • To identify immunogenic surface proteins of Burkholderia pseudomallei.
  • To find potential vaccine candidates and diagnostic targets for melioidosis.

Main Methods:

  • Employed two parallel proteomic approaches: biotinylation for surface protein detection and human serum screening for immunogenicity.
  • Identified 35 surface-located proteins using biotinylation.
  • Detected 12 immunogenic proteins through serum screening.

Main Results:

  • Nine proteins were identified by both biotinylation and serum screening methods.
  • These nine proteins are likely both surface-located and immunogenic.
  • This overlap suggests their high potential as targets.

Conclusions:

  • Identified nine novel B. pseudomallei surface proteins that are immunogenic.
  • These proteins represent promising candidates for future vaccine development and diagnostic tools.
  • Further evaluation of these proteins is warranted for melioidosis control.